Pfizer and BioNTech Vaccine is 97% Effective Against COVID 19
The Pfizer and BioNTech candidate was shown to be 94.5% effective in clinical trials, but in the real world it has been shown to outperform even against newer variants.
The deployment of the vaccine in Israel shows that it is up to 97% effective against new infections and serious conditions of COVID-19.
Discover more stories at Business Insider Spain.
The Pfizer and BioNTech vaccine has proven to be 97% effective against new symptomatic infections of COVID-19, serious cases, and fatal risks, according to data from the Israeli Ministry of Health, reported by the pharmaceutical company.
The unvaccinated were 44 times more likely to suffer from symptomatic COVID-19 and 29 times more likely to die from an infection with the new coronavirus.
“The findings represent the most complete evidence in the real world to date, which demonstrates the effectiveness of a COVID-19 vaccine,” says Pfizer in the statement, which defends that the data also suggests that it prevents asymptomatic infection with SARS-CoV -2.